This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Shanghai Green Valley Pharmaceutical Co., Ltd
Drug Names(s): Sodium Oligo-Mannurarate
Description: Sodium oligo-mannurarate is a heparanase inhibitor. Studies in rat brain indicated that both the core protein and the heparan sulfate glycosaminoglycan chains are required for amyloid fiber formation and deposition in vivo, suggesting that one mechanism to prevent the formation of Abeta-heparan sulfate proteoglycan complexes that lead to deposition of amyloid would be to degrade the proteoglycan.
Sodium Oligo-Mannurarate News
Pink Sheet Maximum Residue Limits
Pink Sheet Xyrem gains daytime claim
Additional information available to subscribers only: